The Marzetti Company MZTI Q1 2026 Earnings EPS Falls Short of Expectations Stock Gains Modestly OESX Q1 2026 Earnings Robust EPS Surprise Highlights Operational Efficiency Gains NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline AP Q4 2025 Earnings Net Loss Reported as Company Navigates Challenging Conditions Fulcrum Therapeutics FULC Q1 2026 Earnings NarrowerthanExpected Loss Despite Mild Stock Dip M Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher